RC-1291 HCl

DRUG2 trials

Sponsors

Helsinn Therapeutics (U.S.), Inc

Conditions

Cancer Cachexia

Phase 2

Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

CompletedNCT00219817

Helsinn Therapeutics (U.S.), IncCancer Cachexia

Start: 2005-06-30End: 2006-10-31Target: 80Updated: 2013-09-02

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

CompletedNCT00267358

Helsinn Therapeutics (U.S.), IncCancer Cachexia

Start: 2005-11-30End: 2006-10-31Updated: 2013-09-02

Related Papers

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.

2014-12-16158 citations